Record #36816
Bevacizumab synergises with the BCL 2 inhibitor venetoclax to effectively treat B-cell non-Hodgkin's lymphoma
Publisher
Original paper date
Jun 18, 2019
Original DOI
Country
Institution
Department of Pharmacy, Zhujiang Hospital, Southern Medical University, Guangzhou, China · The Sixth Affiliated Hospital, Guangdong Institute of Gastroenterology, Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, Supported by National Key Clinical Discipline, Sun Yat-sen University, Guangzhou, China · Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China
Open access
No
Article type
Broad categories
Citation lifecycle
How this paper is being cited
Pre-retraction
5
Same day
1
Post-retraction
2
% post-retraction
25.0%
~1.7 citations/yr before retraction · ~0.5 citations/yr after
— citing papers
Who is still citing this work
Loading…